Macro
Finance
Mid cap
8/6/26 (24d ago)
closed Aug 21, 2026
Entry$20.04Close$24.52PnL+22.33%
Angle Helios is shifting GLXY from crypto beta toward contracted AI infrastructure just as hyperscaler capex stays hot.
Galaxy’s selloff looks tied to crypto volatility and a mixed Q2, but the higher-quality story is that Phase I Helios is now live, with 133MW delivered to CoreWeave and first full-quarter leasing revenue expected around $80M at over 90% project EBITDA margin [
#21,
#33]. The AI data-center angle is also getting a sector tailwind from raised hyperscaler spending and investor focus on compute scarcity, while GLXY is still described as priced like a crypto stock rather than a contracted AI infra name [
#10,
#14,
#29].
Catalyst The re-rating window is the next 3-6 weeks as Q3 Helios leasing revenue visibility and AI infrastructure peer momentum get priced in.
AI Status: GLXY closed with a 22.33% gain in eleven days, capturing nearly all of its 23.30% peak as the Helios AI infrastructure thesis played out.
Macro
Technology
Large cap
7/14/26 (1mo ago)
closed Aug 21, 2026
Entry$97.58Close$118.15PnL+21.08%
Angle The June 29 RSI reclaim is holding above 30 as MSTR tests the low-$90s while BTC liquidity tailwinds reappear.
MSTR’s dip-buy signal has improved: RSI is back above the 30 washout line at 36.45, and the stock is trying to turn from the same low-$90s zone that drew bottoming calls [
#43]. The setup gets help from a softer CPI read that gives Bitcoin a cleaner liquidity backdrop [
#55], while repeat upside call flow near spot shows traders are already positioning for a short-term continuation [
#61].
Catalyst Watch for BTC strength and MSTR holding the $92 area into the next 1-6 weeks as confirmation that the reversal is becoming a tradable trend.
AI Status: MSTR closed with a +21.08% gain after a 28-day dip-buy that peaked near +23.75% before our exit signal.
Agios Pharmaceuticals Inc.
Catalyst
Health Care
Small cap
7/31/26 (1mo ago)
closed Aug 19, 2026
Entry$30.96Close$35.86PnL+15.83%
Angle Mitapivat now has a Nov. 1 PDUFA in sickle cell just as AQVESME launch data is starting to show traction.
Agios has a live FDA catalyst ahead: mitapivat received Priority Review in sickle cell disease with a Nov. 1, 2026 PDUFA date, while Q2 showed $41M of U.S. mitapivat product revenue and 442 cumulative AQVESME prescriptions [
#28,
#41]. Analysts also framed the SCD opportunity as material, with Leerink modeling $554M peak U.S. sales and a 60% probability of success after Priority Review [
#49]. The stock’s washout now has a forward approval window and fresh commercial traction to support a tactical reversal.
Catalyst FDA decision window into the Nov. 1, 2026 PDUFA for mitapivat in sickle cell disease.
AI Status: AGIO closed for a +15.83% gain as the mitapivat sickle cell PDUFA thesis and launch traction played out over 13 days.
Amprius Technologies Inc.
Alpha
Industrials
Small cap
7/15/26 (1mo ago)
closed Aug 14, 2026
Entry$11.34Close$13.04PnL+15.00%
Angle Robotics and drones need lighter batteries, and Amprius is framed as the scarce power-layer supplier into that bottleneck.
Amprius has a structural bounce case because the core debate is shifting from generic battery exposure to whether its high-density cells become essential for drones, humanoid robots, defense use cases, and eVTOL platforms [
#3,
#9,
#11,
#15]. The growth story is also being underwritten by company-specific operating leverage: management is described as using a flexible asset-light production model, while 2026 revenue guidance is cited at at least $130M, or 70%+ YoY growth [
#5,
#14,
#15].
Catalyst A re-rating can come as investors underwrite the 2026 revenue ramp and physical-autonomy battery demand over the next several weeks.
AI Status: Amprius closed at +15.00% after 22 trading days, locking in gains as the high-density battery thesis matured before our exit signal.
Capricor Therapeutics Inc.
Catalyst
Health Care
Small cap
7/31/26 (1mo ago)
closed Aug 14, 2026
Entry$3.93Close$7.74PnL+97.20%
Angle A negative AdCom may have washed out CAPR before the still-open Aug. 22 PDUFA decision.
CAPR has collapsed after FDA briefing concerns and a 3-9 AdCom vote, but the forward setup is still the August 22 PDUFA for Deramiocel rather than the already-fired panel reaction [
#28,
#32,
#38]. The bull case is that FDA could still approve or conditionally approve on a narrower DMD label, with supporters pointing to PUL/LVEF arguments, SAP process defenses, and published 54% slowing of upper-limb decline in The Lancet [
#2,
#17,
#20,
#21,
#24]. That makes the trade a high-risk regulatory mean reversion: the stock has repriced for failure, while the final agency decision remains open.
Catalyst FDA’s Aug. 22, 2026 PDUFA target action date for Deramiocel is the re-rating event.
AI Status: CAPR closed for a +97.2% gain after ten days, exiting on our exit signal after peaking near +109% amid post-AdCom volatility ahead of the Aug. 22 PDUFA.
Earnings
Technology
Mid cap
7/31/26 (1mo ago)
closed Aug 13, 2026
Entry$118.69Close$140.90PnL+18.71%
Angle Q2 EPS growth is still on deck after a 30% reset, with AI-server PCB demand and A&D backlog intact.
TTMI has already absorbed a sharp valuation reset, falling roughly 30% from the prior week’s highs while the AI-server PCB story, $1.6B aerospace-defense backlog, and Penang yield progress remain intact [
#1]. The Q2 preview still flags consensus EPS growth and exposure to high-layer-count PCB/RF demand tied to AI-server, networking, and aerospace-defense markets [
#2]. Large bullish call flow into the rebound window adds confirmation that buyers are positioning for a pre/post-earnings re-rate rather than treating the washout as broken momentum [
#5,
#7].
Catalyst The Q2 earnings window and Aug. 21 call-expiration positioning are the near-term re-rating setup.
AI Status: TTMI closed for a +18.71% gain after a nine-day rebound from the valuation reset as our exit signal ended the hold.
Alpha
Technology
Mid cap
8/5/26 (25d ago)
closed Aug 12, 2026
Entry$5.55Close$6.43PnL+15.86%
Angle Honda validation plus 90% Eagle readiness make the post-earnings washout look like a commercialization reset.
QuantumScape sold off after Q2 even though the loss beat, expenses fell, billings rose, CapEx guidance was lowered, Eagle Line kept running, and Honda remained engaged [
#3]. The stronger alpha case is that the story is broadening beyond Volkswagen: Eagle readiness is near 90%, defense cells have begun shipping, and AI data-center and defense applications add new commercialization paths [
#6,
#15]. The PowerCo amendment remains the overhang, but several updates argue it is a milestone-payment restructuring rather than a broken partnership [
#2,
#26].
Catalyst Further Eagle Line readiness/yield disclosures, defense shipment progress, and any supply or DoD contract update are the 2-5 week re-rating window.
AI Status: QuantumScape closed for a +15.86% gain in five days after the post-earnings rebound validated the commercialization reset thesis until our exit signal.
Boston Scientific Corporation
Contrarian
Health Care
Large cap
7/6/26 (1mo ago)
closed Aug 11, 2026
Entry$44.60Close$50.99PnL+14.33%
Angle A full round trip to 2022 support leaves BSX priced far below sell-side targets as buyback support absorbs the flush.
BSX has been punished like a broken compounder despite an active buyback, with the accelerated repurchase at $52.68 now far above spot and highlighting the severity of the capitulation [
#2]. The reversal case is sentiment and positioning: shares have round-tripped to 2022 levels near a historic support trendline, while referenced upside to average analyst targets remains unusually wide [
#4,
#5].
Catalyst Second-half mean reversion as support holds and investors revisit the analyst-target gap after the forced selling phase.
AI Status: BSX closed with a +14.33% realized gain after a 26-day rebound from 2022 support, finishing just 0.45% below peak.
Alpha
Industrials
Small cap
7/31/26 (1mo ago)
closed Aug 7, 2026
Entry$4.07Close$4.72PnL+15.97%
Angle An ex-Apple product-ops leader is taking over the manufacturing ramp just as the stock rebounds from a washout.
Enovix now has a clearer execution reset: Dr. Michael Vyvoda, formerly Apple’s Director of Product Operations for Audio Products, was appointed COO to lead the global manufacturing ramp [
#1,
#9]. The structural case is not just smartphones; the South Korea defense battery business is already paying bills and has an emerging drone growth market, while Q1 revenue grew 49% YoY to $7.6M and exceeded guidance [
#4,
#9].
Catalyst Re-rating depends on evidence that the new COO can translate the manufacturing ramp into stronger commercial rollout and operating updates over the next 1-2 months.
AI Status: ENVX closed with a +15.97% gain in five sessions as the COO-led manufacturing ramp thesis played through a sharp rebound.
Contrarian
Finance
Mid cap
7/2/26 (1mo ago)
closed Aug 6, 2026
Entry$2.17Close$1.18PnL-45.73%
Angle KBW's Outperform upgrade gives UWMC a fresh risk-reward reset after rate, leverage, and dividend fears washed out the stock.
UWMC's bounce has a tweet-backed sentiment hook: Keefe Bruyette upgraded UWM to Outperform while setting a $3.75 target, materially above the $2.22 close [
#1,
#15]. The setup is contrarian because BTIG's cited pushback says the stock remains weak on rate, leverage, and dividend concerns, so the upgrade suggests the bearish narrative may be over-discounted as daily momentum turns [
#8].
Catalyst The re-rating window is the next 1-6 weeks as investors digest KBW's upgrade against a crowded negative mortgage-lender narrative.
AI Status: UWMC closed at a 45.73% loss after the KBW upgrade bounce failed and the stock kept grinding lower in a entrenched downtrend.
Vishay Intertechnology Inc.
Earnings
Technology
Mid cap
7/31/26 (1mo ago)
closed Aug 4, 2026
Entry$34.64Close$39.01PnL+12.60%
Angle August 5 earnings give VSH a near-term re-rate window after Q1 demand recovery and semi washout positioning.
VSH has a near-term earnings setup with the next print scheduled for 08/05 after a semiconductor washout, and traders are looking at 08/21 upside calls as the rebound window [
#3]. The setup is supported by Q1 revenue up 17% YoY to $839M, margin expansion to 21%, and demand recovery [
#6], plus expectations that names like VSH could follow the recent semiconductor earnings-beat pattern [
#5].
Catalyst The August 5 earnings report is the re-rating event, with the trade expected to resolve into the print and immediate post-report reaction.
AI Status: VSH closed with a 12.60% gain in two trading days, capturing most of the rebound ahead of the August 5 earnings catalyst.
Alpha
Consumer Discretionary
Small cap
7/31/26 (1mo ago)
closed Aug 4, 2026
Entry$21.27Close$28.16PnL+32.37%
Angle Data-center infrastructure expertise just joined the board as AMRC’s JV-backed growth runway gets re-priced.
Ameresco’s reversal has a concrete fundamental hook: Brian Cox, founder and former CEO of STACK Infrastructure, has joined the board, adding relevant infrastructure expertise at a washed-out point for the stock [
#1]. The broader growth case is still alive, with analysts framing 61% upside, Q1 revenue up 14%, and a $400M HASI biofuels JV supporting the runway [
#2].
Catalyst A board-level infrastructure upgrade plus continued analyst support can drive a 1-6 week re-rate as investors revisit the biofuels and clean-infrastructure growth case.
AI Status: Ameresco closed with a +32.4% gain in two sessions after our exit signal captured most of a sharp reversal rally.
Kratos Defense & Security Solutions Inc.
Catalyst
Industrials
Mid cap
7/13/26 (1mo ago)
closed Aug 4, 2026
Entry$46.96Close$51.71PnL+10.11%
Angle A billion-dollar-plus hypersonics award is still ahead as valuation has reset despite improving fundamentals.
KTOS has a forward catalyst in the expected official announcement of a billion-dollar-plus hypersonic contract, alongside potential Taiwan Mighty Hornet demand [
#2]. The setup is reinforced by IR-confirmed commentary around a potential $10 billion future annual revenue opportunity and Jefferies reiterating Buy with an $80 target on valuation de-rating, margin expansion, and a positive fundamental outlook [
#1,
#5].
Catalyst Official confirmation of the billion-dollar-plus hypersonics award and related defense order flow could re-rate the stock over the next several weeks.
AI Status: KTOS closed with a +10.11% gain after sixteen days as the hypersonics catalyst thesis partially played out before our exit signal ended the trade.
NuScale Power Corporation
Catalyst
Industrials
Mid cap
7/27/26 (1mo ago)
closed Aug 4, 2026
Entry$8.41Close$9.53PnL+13.33%
Angle ATM dilution risk may be nearly cleared just as the Aug. 5 PPA update window comes into focus.
NuScale’s tactical bounce has a concrete why-now hook: the Q2 call is set for Aug. 5, with investors watching for PPA progress tied to ENTRA1 and TVA [
#2]. The setup is strengthened by estimates that the $1B ATM is likely complete or nearly complete, shifting the debate from dilution pressure toward ATM clarity, commercial de-risking, and binding contract value [
#8,
#10]. July nuclear policy support and AI data-center power demand add sector-level pressure for the advanced nuclear trade to re-rate [
#7].
Catalyst The re-rating window is the Aug. 5 Q2 call and any update on ENTRA1/TVA PPA progress or remaining ATM dilution.
AI Status: NuScale Power closed the SMR pick with a +13.33% realized gain after a six-day tactical bounce into the Aug. 5 catalyst window.
Macro
Technology
Small cap
7/31/26 (1mo ago)
closed Aug 3, 2026
Entry$60.77Close$70.74PnL+16.41%
Angle Record InP revenue and 45% gross margin show AI optics demand is turning a washout into a supply-cycle rebound.
AXT just posted a step-change quarter: revenue rose 164%-165% YoY to $47.6M, gross margin expanded to roughly 45%, and InP revenue hit a record $30.7M as AI data-center optics demand accelerated [
#3,
#22,
#33]. The stronger case is not just the earnings beat, but upstream confirmation that InP substrates are supply-constrained as 800G/1.6T optical deployments ramp [
#6,
#8]. After a severe drawdown from the prior speculative peak, those operating receipts support the idea that the tactical bounce has real sector fuel behind it [
#5,
#30].
Catalyst Continuation of AI optical connectivity demand, InP supply tightness, and Q3 revenue guidance follow-through should drive the next re-rating window.
AI Status: AXTI closed after one session with a +16.41% gain as record InP revenue and AI optics demand validated the thesis before our exit signal.
Hamilton Lane Incorporated
Insider
Finance
Mid cap
7/1/26 (2mo ago)
closed Aug 3, 2026
Entry$78.66Close$92.41PnL+17.47%
Angle Three executives put $2m into HLNE near the washout, turning a rate-wobble selloff into an insider-backed bounce.
HLNE has a clean why-now signal: three executives just bought $2m of stock after a 35% decline below its 200-day line, with no insider selling into the drawdown [
#1]. The narrative is not just technical; Hamilton Lane is still described as a leading private-markets specialist with about $1.05T in AUM/advisement and growth tied to high-margin retail Evergreen expansion [
#2].
Catalyst The re-rating window is the next few weeks as the market digests the recent insider-buy disclosure and reassesses the rate-wobble selloff.
Insider signal [CLUSTER] Three Hamilton Lane executives just bought $2m of stock near the lows, with no insider sales cited during the decline.
AI Status: HLNE closed with a +17.5% gain after the insider-backed bounce played out and price reclaimed momentum above its short-term trend line.
Huntington Ingalls Industries Inc.
Alpha
Industrials
Large cap
6/26/26 (2mo ago)
closed Jul 30, 2026
Entry$281.99Close$317.86PnL+12.72%
Angle Cheapest defense prime at ~15x 2027 EPS vs RTX 24x and GD 19x — with a $54B backlog the tape is pricing as fiction.
Down 21% over six months on almost entirely company-specific selling, HII now trades at ~15x 2027 earnings versus RTX at 24x and GD at 19x while sitting on a $54B backlog and a Moderate Buy consensus [
#4,
#5]. A fresh $418M five-year Navy IDIQ award for carrier and amphibious elevator maintenance through 2031 underscores that the backlog is real and recurring, not impaired [
#1,
#2,
#11]. With the drawdown company-specific and the order book intact, the multiple gap to peers is the mispricing the reversal is starting to close.
Catalyst Backlog conversion and analyst re-rating toward defense-prime peer multiples as 2027 earnings power comes into view.
AI Status: HII closed at +12.72% after the defense-prime discount thesis played out and our exit signal ended the pick at peak gains.
Miami International Holdings Inc.
Alpha
Finance
Mid cap
6/25/26 (2mo ago)
closed Jul 28, 2026
Entry$36.74Close$45.11PnL+22.78%
Angle A low-latency exchange operator with 40% net revenue growth and a debt-free balance sheet is being treated like insider-selling noise.
The MIAX bull case is structural: tweets highlight a clearing-house model that can generate new products and incentivize liquidity [
#3]. Another thesis post argues the market is missing a compounder with 40% YoY net revenue growth, debt cleared, and $550M cash while focusing on temporary insider selling [
#41].
Catalyst Re-rating can come as investors look past post-listing insider-selling concerns and underwrite MIAX’s product-growth runway.
AI Status: MIAX closed with a +22.78% gain after our exit signal ended the trade near its peak.
Alpha
Technology
Mega cap
6/25/26 (2mo ago)
closed Jul 27, 2026
Entry$255.07Close$306.68PnL+20.23%
Angle AI tax-prep fears have compressed Intuit to crisis-like multiples despite a moat that bulls say has not moved.
Tweets frame Intuit as a quality compounder washed out by AI and TurboTax-growth fears, not a broken franchise: bulls cite 50M+ sticky tax and small-business customers, 30-year revenue consistency, and a dominant software/fintech footprint [
#19,
#23,
#24]. The why-now is valuation plus capital return, with posts citing low earnings/FCF multiples and an $8B buyback authorization that could retire about 11% of shares [
#1,
#12,
#13].
Catalyst The trade should re-rate as AI-displacement fears stabilize and buyback/quality-compounder arguments regain investor attention over the next several weeks.
AI Status: Intuit closed at +20.23% after a 32-day run that peaked near +21% and gave back less than 1% from the high.
Cognizant Technology Solutions
Alpha
Technology
Large cap
6/29/26 (2mo ago)
closed Jul 27, 2026
Entry$38.74Close$47.37PnL+22.28%
Angle A 2026 buyback equal to about 10.5% of market cap gives CTSH a concrete EPS lever as momentum turns.
CTSH has a tweet-backed value and capital-return setup: one post estimates 2026 repurchases at about $2B, or 10.5% of market cap, implying meaningful EPS accretion even before growth or M&A [
#1]. The valuation case is reinforced by comments that CTSH trades around 9x earnings versus peers near 31x and screens at a much lower forward PEG under a 6% sales-growth base case with buybacks and dividends [
#8,
#9]. A device-demand rebound narrative adds a sector tailwind for the tactical bounce window [
#3].
Catalyst The re-rating window is 2026 buyback execution alongside renewed evidence that device-demand recovery can support IT-services growth.
AI Status: CTSH closed for a 22.3% realized gain after the buyback-and-value thesis largely played out over a 28-day hold.
Booz Allen Hamilton Holding Corporation
Macro
Consumer Discretionary
Mid cap
7/6/26 (1mo ago)
closed Jul 24, 2026
Entry$62.31Close$75.47PnL+21.12%
Angle DOGE’s shutdown removes a contract-cancellation overhang just as July defense-budget markers come into view.
BAH’s washout has a clearer why-now hook than a simple chart bounce: DOGE’s July 4 wind-down follows an 18-month period of federal contract cancellations, including 31 Treasury contracts tied to BAH in January [
#1]. The bull case is that defense and intelligence demand remains the higher-quality federal-services sleeve, while July NDAA, DoD budget, SDA allocation, and BAH earnings markers can reset the narrative [
#7,
#10].
Catalyst July defense-budget and NDAA updates, SDA Tranche 3 allocation signals, and the next BAH earnings call are the re-rating window.
AI Status: BAH closed at +21.12% after an 18-day rebound from the federal-contract washout, capturing nearly the full peak before our exit signal.
Circle Internet Group Inc.
Earnings
Finance
Large cap
7/17/26 (1mo ago)
closed Jul 20, 2026
Entry$60.46Close$66.78PnL+10.45%
Angle August earnings now sit behind record $1.21T June volume and 67% share after a 40% pullback into support.
Circle has a near-term earnings re-rate setup: Q2 is due in roughly three weeks, the prior report beat and produced a 20% stock reaction, and recent data cited record $1.21T June volume with 67% share [
#4,
#15]. The selloff is being framed as over-discounting take-rate compression while assigning too little value to Circle's regulatory and liquidity advantages after OCC approval [
#17,
#20].
Catalyst Q2 earnings in August are the re-rating window, with June volume/share data setting up the surprise case.
AI Status: CRCL closed with a 10.45% gain in 3.2 days as our exit signal locked in the earnings-rebound bounce tied to record stablecoin volume.
Alpha
Industrials
Mid cap
7/13/26 (1mo ago)
closed Jul 20, 2026
Entry$4.55Close$5.34PnL+17.36%
Angle ACHR's RSI reclaimed 30 and is holding near 39, showing dip buyers defended the first reversal attempt.
ACHR's washout looks like it is giving way to a tradeable reversal, with RSI back above the key 30 line and price stabilizing around $4.73. That shift matters because the stock does not need a full sentiment reset to work from here; it needs follow-through that confirms buyers are stepping in before momentum gets crowded again.
Catalyst Watch for a close above the recent rebound range to confirm the RSI cross-up is turning into sustained upside momentum.
AI Status: ACHR closed with a +17.36% gain after the reversal thesis played out in just over a week.
Catalyst
Consumer Discretionary
Mid cap
6/25/26 (2mo ago)
closed Jul 7, 2026
Entry$7.26Close$8.08PnL+11.30%
Angle Intermex approval news gives Western Union a live deal catalyst just as bears argue the stock over-discounted revenue erosion.
Western Union has a forward M&A hook: the company and Intermex issued an update on the pending acquisition approval process [
#14,
#17]. The reversal has a narrative beyond a cheap stock because bulls argue revenue fell from about $5B to $4B while the equity fell far more than fundamentals justify [
#8,
#45].
Catalyst The pending Intermex acquisition approval process is the near-term re-rating window.
AI Status: Western Union closed at +11.30% after twelve days as the Intermex approval thesis played out near the trade peak.